Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Cell type, High grade lymphoma, Leukaemia, Lymphoma, Myelodysplastic syndrome (MDS), Myeloma, Non-Hodgkin lymphoma (NHL)
Open
Phase 1/2
This trial is for people with blood cancer that has come back or is getting worse despite treatment.
It is for people with one of the following types of blood cancer:
high risk myelodysplastic syndrome (MDS) – this means the MDS has a high risk of developing into leukaemia
Recruitment start: 9 September 2019
Recruitment end: 31 December 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Somervaille
CellCentric Ltd
Last reviewed: 16 December 2024
CRUK internal database number: 17062
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
